Clinical Trials Browser

Phase 3 × Melanoma × Drug Therapy × Clear all

NCT02278887 2025-03-10

TIL

Phase 3 Completed

Melanoma

NCT01245062 2018-04-05

GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma

Phase 3 Completed

322 enrolled 24 charts

Melanoma, Neoplasms